Development of a Nomogram Model for Treatment of Elderly Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

Código QR

Development of a Nomogram Model for Treatment of Elderly Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

(<b>1</b>) Purpose: This study aims to explore risk-adapted treatment for elderly patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) according to their pretreatment risk stratification and the degree of comorbidity. (<b>2</b>) Methods: A total of 583 elde...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jia Kou, Lu-Lu Zhang, Xing-Li Yang, Dan-Wan Wen, Guan-Qun Zhou, Chen-Fei Wu, Si-Si Xu, Wei-Hong Zheng, Zhen-Yu Qi, Ying Sun, Li Lin
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	nasopharyngeal carcinoma elderly patients comorbidities chemotherapy Medicine R
Acceso en línea:	https://doaj.org/article/46b4b49c0ab74614b72f9933a09ef38f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
por: Su Z, et al.
Publicado: (2020)

Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy
por: Da-wei Zhao, et al.
Publicado: (2021)

Role of regenerating gene IA expression on local invasion and survival in nasopharyngeal carcinoma
por: Xing,Haijie, et al.
Publicado: (2017)

Nasopharyngeal carcinoma – Improving cure with technology and clinical trials
por: Raymond K. Tsang
Publicado: (2020)

Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options
por: Zheran Liu, et al.
Publicado: (2021)

Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
por: Zhen Zeng, et al.
Publicado: (2018)

Profile of Obesity and Comorbidities in Elderly Patients with Heart Failure
por: Dădârlat-Pop A, et al.
Publicado: (2020)

A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma
por: Li WZ, et al.
Publicado: (2021)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
por: Lv SH, et al.
Publicado: (2021)

Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II–IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
por: Jie Yang, et al.
Publicado: (2021)

Optimal management of renal cell carcinoma in the elderly: a review
por: Quivy A, et al.
Publicado: (2013)

Neutrophil Lymphocyte Ratio, Three Year Survival of Locally Advanced and Advanced Nasopharyngeal Carcinoma
por: Rahmat Cahyanur, et al.
Publicado: (2021)

Polyethylene Glycol-Coated Graphene Oxide Loaded with Erlotinib as an Effective Therapeutic Agent for Treating Nasopharyngeal Cancer Cells
por: Lan MY, et al.
Publicado: (2020)

Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma
por: Peng RR, et al.
Publicado: (2021)

The Role of Genetic Pathways in the Development of Chemoradiation Resistance in Nasopharyngeal Carcinoma (NPC) Patients
por: Norhafiza Mat Lazim, et al.
Publicado: (2021)

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Qian-Ying Zhu, et al.
Publicado: (2020)

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
por: Kin-Sang Lau, et al.
Publicado: (2021)

Src-1 and SP2 promote the proliferation and epithelial–mesenchymal transition of nasopharyngeal carcinoma
por: Zhang Jingjing, et al.
Publicado: (2021)

Subspecies Niche Specialization in the Oral Microbiome Is Associated with Nasopharyngeal Carcinoma Risk
por: Justine W. Debelius, et al.
Publicado: (2020)

Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
por: Ya-Nan Jin, et al.
Publicado: (2021)

Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
por: Xiao J, et al.
Publicado: (2021)

Dysphagia after chemo-radiation for nasopharyngeal cancer: A scoping review
por: Raymond Fong, et al.
Publicado: (2020)

Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma
por: Yang,Ju-Hong, et al.
Publicado: (2019)

Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90
por: Hong-Mei Li, et al.
Publicado: (2021)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
por: Jing-Feng Zong, et al.
Publicado: (2021)

Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities
por: Arahata M, et al.
Publicado: (2018)

Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma
por: Yan Wang, et al.
Publicado: (2021)

Research Progress of Carotid Artery Injury Caused by Radiotherapy for Nasopharyngeal Carcinoma
por: XIE Zhiwei, et al.
Publicado: (2021)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Alberto Fresa, et al.
Publicado: (2021)

Predictors of Handgrip Strength Changes in Elderly Patients
por: Ummi Ulfah Madina, et al.
Publicado: (2021)

Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern era
por: Sarbani Ghosh-Laskar, et al.
Publicado: (2020)

The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
por: Ling‐Long Tang, et al.
Publicado: (2021)

Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma
por: Xiandong Lin, et al.
Publicado: (2021)

Cerebral Structural Abnormalities and Their Associations With Peripheral Cytokine Levels in a Group of Untreated Patients With Nasopharyngeal Carcinoma
por: Yan Wang, et al.
Publicado: (2021)

Dose Prediction Using a Three-Dimensional Convolutional Neural Network for Nasopharyngeal Carcinoma With Tomotherapy
por: Yaoying Liu, et al.
Publicado: (2021)

In Vivo Imaging Markers for Prediction of Radiotherapy Response in Patients with Nasopharyngeal Carcinoma: RESOLVE DWI versus DKI
por: Wei-Yuan Huang, et al.
Publicado: (2018)

Anti-PD-1 Therapy—A Potential Treatment for Myocardial Metastasis From Nasopharyngeal Carcinoma: A Case Report
por: Xiaowan Tang, et al.
Publicado: (2021)

Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p
por: Ning Jiang, et al.
Publicado: (2021)

Nasopharyngeal Swabs vs. Nasal Aspirates for Respiratory Virus Detection: A Systematic Review
por: Matthew F. Flynn, et al.
Publicado: (2021)

CD4-positive lymphoepithelial-like carcinoma: Report of unusual case
por: Luaay Aziz, et al.
Publicado: (2018)